CLINICAL_TRIALS
trial_result
· 2024-01-16
Clinical Trial Update: Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines [Phase 3]
Summary
Phase 3 clinical trial comparing HG102 to Botox in adults with moderate to severe glabellar lines to evaluate safety and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hugel | Conditions: Glabellar Lines | Phase 3 | Status: UNKNOWN